Emerald Health Therapeutics Announces .5 Million Prospectus Sale and Concurrent Secondary Sale
Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Investor has agreed, subject to certain customary conditions, to purchase 4,385,965 units of Emerald (each, a “Unit”) at a price of $0.57 per Unit for total gross proceeds of $2,500,000 (the “Offering”). Each Unit will consist of one common share of Emerald (each, a “Common Share”) and one common share purchase warrant (each, a “Warrant”). READ MORE: https://finance.yahoo.com/news/emerald-health-therapeutics-announces-2-142800655.html?.tsrc=rss The post Emerald Health Therapeutics Announces $2.5 Million Prospectus Sale and Concurrent Secondary Sale appeared first on Cannabis Daily.
Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Emerald Health Therapeutics Announces .5 Million Prospectus Sale and Concurrent Secondary Sale
reposted by Cannabis News World
You must log in to post a comment.